相关实验视频

Updated: Jul 12, 2025

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

Published on: July 30, 2019

通过对线粒体的干扰,准急性髓性白血病干细胞

Anagha Inguva Sheth¹, Krysta Engel^1,2, Hunter Tolison^1,2

¹Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA.

bioRxiv : the preprint server for biology

|October 24, 2023

概括

急性髓性白血病干细胞依赖于氧化酸化 (OXPHOS). 通过使用MCU抑制剂向线粒体,通过减少OXPHOS来消除venetoclax耐药的LSCs.

科学领域:

血液学血液学血液学
癌症生物学癌症生物学
线粒体生物学线粒体生物学

背景情况:

急性髓性白血病干细胞 (LSCs) 需要氧化酸化 (OXPHOS) 才能生存.
维护OXPHOS的关键是BCL2蛋白,它是venetoclax的LSC的治疗标.
威尼托克拉克斯耐药性是一个重大的临床挑战,需要对耐药性机制进行研究.

研究的目的:

调查药物响应性与非响应性LSC中的线粒体利用率.
确定线粒体在venetoclax耐药性中的作用.
确定克服venetoclax耐药性的新型治疗策略.

主要方法:

对维内托克拉克斯敏感和耐药的LCS中线粒体水平的比较分析.
评估与水平相关的OXPHOS状态.
线粒体单载体 (MCU) 的遗传和药理抑制.

主要成果:

维内托克拉克斯耐药的LSCs表现出更高的OXPHOS活性和较高的线粒体.
抑制MCU显著降低了抗性LSC中的OXPHOS.
针对MCU的向导致了对venetoclax耐药的LSCs的根除.

结论:

线粒体信号传递在LSC生物学中起着至关重要的作用.
针对MCU提供了一个潜在的治疗策略,以克服AML中的venetoclax耐药性.
这项研究发现了对venetoclax耐药的LSCs的新脆弱性.

更多相关视频

Simultaneous Measurement of Mitochondrial Calcium and Mitochondrial Membrane Potential in Live Cells by Fluorescent Microscopy

Simultaneous Measurement of Mitochondrial Calcium and Mitochondrial Membrane Potential in Live Cells by Fluorescent Microscopy

Published on: January 24, 2017

Analyses of Mitochondrial Calcium Influx in Isolated Mitochondria and Cultured Cells

Analyses of Mitochondrial Calcium Influx in Isolated Mitochondria and Cultured Cells

Published on: April 27, 2018

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...